alpha-aminopyridine has been researched along with Kidney Diseases in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 3 (37.50) | 2.80 |
| Authors | Studies |
|---|---|
| Kashizaki, F; Sekido, Y; Tanaka, A | 1 |
| Edelman, A; Gauthier, S; Guerrera, IC; Hinzpeter, A; Jung, V; Martignetti, L; Nguyen-Khoa, T; Pranke, I; Semeraro, M; Sermet-Gaudelus, I; Stoven, V | 1 |
| Beaver, L; Byrd, JC; Cannon, M; Harrington, B; Lapalombella, R; Lehman, A; Mitchell, S; Sampath, D; Zhang, P | 1 |
| Aloliet, RI; Ansari, MN; Ganaie, MA; Hamad, AM; Imam, F; Khan, TH | 1 |
| de Mey, C; Deliyska, B; Gatchev, E; Terhaag, B | 1 |
| Gillen, M; Marbury, T; Martin, P; Millson, D; Oliver, S | 1 |
| Miller, RD | 1 |
| Abrams, SM; Ankier, SI; Baker, LR; Crome, P; Johnston, A; Niebch, G; Turner, P; Warrington, SJ; White, AS | 1 |
1 review(s) available for alpha-aminopyridine and Kidney Diseases
| Article | Year |
|---|---|
Recent developments with muscles relaxants and their antagonists.
Topics: Acidosis; Aminopyridines; Electric Stimulation; Humans; Hypothermia; Kidney Diseases; Liver Diseases; Neostigmine; Neuromuscular Blocking Agents; Neuromuscular Junction; Pancuronium; Peripheral Nerves; Respiration; Sensory Receptor Cells; Synaptic Transmission; Water-Electrolyte Balance | 1979 |
2 trial(s) available for alpha-aminopyridine and Kidney Diseases
| Article | Year |
|---|---|
Effects of advanced age and renal dysfunction on the single- and repeated-dose pharmacokinetics of modified-release flupirtine.
Topics: Administration, Oral; Adult; Age Factors; Aged; Aging; Aminopyridines; Analgesics; Area Under Curve; Biomarkers; Creatinine; Delayed-Action Preparations; Drug Administration Schedule; Drug Monitoring; Female; Glomerular Filtration Rate; Humans; Kidney; Kidney Diseases; Male; Metabolic Clearance Rate; Middle Aged; Prospective Studies; Severity of Illness Index; Young Adult | 2015 |
Pharmacokinetic Properties of Fostamatinib in Patients With Renal or Hepatic Impairment: Results From 2 Phase I Clinical Studies.
Topics: Aminopyridines; Arthritis, Rheumatoid; Female; Humans; Kidney Diseases; Liver Diseases; Male; Middle Aged; Morpholines; Oxazines; Protein Kinase Inhibitors; Pyridines; Pyrimidines | 2015 |
5 other study(ies) available for alpha-aminopyridine and Kidney Diseases
| Article | Year |
|---|---|
Efficacy of lorlatinib after alectinib-induced interstitial lung disease in a patient with anaplastic lymphoma kinase-positive non-small cell lung cancer: a case report.
Topics: Aminopyridines; Anaplastic Lymphoma Kinase; Antineoplastic Agents; Carbazoles; Carcinoma, Non-Small-Cell Lung; Humans; Kidney Diseases; Lactams; Lung Diseases, Interstitial; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Piperidines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrazoles | 2022 |
Urinary Exosomes of Patients with Cystic Fibrosis Unravel CFTR-Related Renal Disease.
Topics: Adolescent; Adult; Aminophenols; Aminopyridines; Benzodioxoles; Case-Control Studies; Child; Child, Preschool; Cystic Fibrosis; Drug Combinations; Exosomes; Humans; Indoles; Kidney Diseases; Proteome; Quinolones; Young Adult | 2020 |
Anti-tumor NAMPT inhibitor, KPT-9274, mediates gender-dependent murine anemia and nephrotoxicity by regulating SIRT3-mediated SOD deacetylation.
Topics: Acetylation; Acrylamides; Aminopyridines; Anemia; Animals; Antineoplastic Agents; Erythropoiesis; Female; Humans; Kidney Diseases; Male; Mice; Nicotinamide Phosphoribosyltransferase; Sex Factors; Sirtuin 3; Superoxide Dismutase | 2021 |
Roflumilast, a phosphodiesterase 4 inhibitor, attenuates cadmium-induced renal toxicity via modulation of NF-κB activation and induction of NQO1 in rats.
Topics: Aminopyridines; Animals; Benzamides; Cadmium Chloride; Catalase; Creatinine; Cyclopropanes; Glutathione; Kidney; Kidney Diseases; Male; NAD(P)H Dehydrogenase (Quinone); NF-kappa B; Phosphodiesterase 4 Inhibitors; Rats, Wistar; Superoxide Dismutase; Urea | 2019 |
Pharmacokinetics of flupirtine in elderly volunteers and in patients with moderate renal impairment.
Topics: Age Factors; Aged; Aged, 80 and over; Aminopyridines; Female; Half-Life; Humans; Kidney; Kidney Diseases; Male; Metabolic Clearance Rate; Middle Aged | 1988 |